Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride

Pharmazie

Volumn 58, Issue 1, 2003, Pages 38-43

  Moursy, N M ^a   Afifi, N N ^a   Ghorab, D M ^a   El Saharty, Y ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; MICARD; NICARDIPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BUOYANCY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CHOICE; DRUG DETERMINATION; DRUG FORMULATION; DRUG MIXTURE; DRUG SCREENING; DRUG SOLUBILITY; HYDROCOLLOID; HYPERTENSION; MALE; NONHUMAN; PLASMA; POLYMERIZATION; POWDER; RABBIT; RADIATION DETECTION; RECEPTOR BLOCKING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUSTAINED RELEASE PREPARATION; TABLET PROPERTY; ULTRAVIOLET RADIATION; VASODILATATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CALIBRATION; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; MALE; NICARDIPINE; RABBITS; SOLUBILITY;

EID: 0037255833     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Takenaka, T.; Usuda, T.; Nomura, T.; Maeno, H.; Sado, T.: Arzneim. Forsch. 26, 2172 (1976)
2. Hof, R. P.: Br. J. Pharmac. 78, 375 (1983)
3. Agre, K.: Am. J. Cardiol. 59, 31 (1987)
4. Jones, R. I.; Hornung, R. S.; Soneha, T.; Rafteiy, E. B.: J. Hypertens. 1, 85 (1983)
5. th Ed., Vol. I, USPDI, pp. 695-704 (1996)
6. Conrad, K. A.; Fagan, T. C.: in "Therapeutic Drugs", Dollery, C., ed., p. 56 (1991)
7. Delchier, J. C.; Guerret, M.; Vidon, N.; Dubarcy, C.; Lavene, D.: Eur. J. Clin. Pharmac. 26, 435 (1988)
8. Goldberg, M. E.; Clark, S.; Josef, J.; Mortiz, H.; Maguire, D.; Seltzer, J. L.; Turlapaty, P.: Am. Heart J. 119, 446 (1990)
9. Graham, D. J. M.: Br. J. Clin. Pharmacol. 20, 235 (1985)
10. Prochet, H. C.; Dayer, P.: Clin. Pharmacol. Ther., 48, 155 (1990)
11. Yüksel, H.; Tincer, T.; Baykara, T.: Int. J. Pharm. 140, 146 (1996)
12. Budavari, S.: "Merck Index", Merck Research Laboratories and Co., Inc. Whitehouse Station, NJ. p. 6580(1996)
13. Mohammed, I. A.: Ph. D. Thesis in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, Egypt 1996
14. Gerogianis, V. S.; Rekkas, D. N.; Dallas, P. P.; Choulis, N. H.: Drug Dev. Ind. Pharm. 19, 1061 (1993)
15. Tossounian, J. L.; Mergens, W. J.; Sheth, P. R.: Drug Dev. Ind. Pharm. 11, 1019 (1985)
16. Timmermans, J.; Moes A. J.: Int. J. Pharm. 62, 207 (1990).
17. Talukdar, M. M.; Michoel, A.; Rombaut, P.; Kinget, R,: Int. J. Pharm. 129, 233 (1996)
18. Mosquera, M. J.; Cauna, M.; Souto, C.; Conchiero, A.; Martinez-Pacheco, R.; Gomez-Amoza, J. L.: Int. J. Pharm. 135, 147 (1996)
19. El-Bardicy, M.; El-Saharty, Y. S.; Tawakkol, M. S.: Talanta 40 (4), 577 (1993).
20. Eastwood, R. J.; Galustian, R. K.; Bahamra, R. K.; Holt, D. W.: J. Chromatogr. 530, 467 (1990)
21. Wu, A. T.; Massey, I., J.; Kushinsky, S.: J. Pharm. Sci. 73 (10), 1444 (1984)
22. Huang, H.; Li, H.: Yaowu Funxi Zazhi. 10 (6), 359 (1990). Per Analytical Abstracts 5305 G116.
23. Nobus, K.; Iwao, T.; Hirai, K. I.; Fukuda, M.; Yamanouchi, K.; Yokoyama, K.; Miyaji, M.; Ishihara, Y.; Kon, K.; Ogawa, Y.; Mayumi, T.: J. Pharm. Sci. 83, 566 (1994)
24. Ingani, H. M.; Timmermans, J.; Moes, A. J.: Int. J. Pharm. 35, 157 (1987)
25. Paget and Barnes: in "Evaluation of drug activities", vol. I. p. 53 Academic Press. (1964)